Hartley Lindsey Marie 🟡 adjusted position in 14.5K shares (2 derivative) of Axogen, Inc. (AXGN) at $32.84 Transaction Date: Mar 16, 2026 | Filing ID: 000047
📋 Dennis Phillip Andrew (Chief Medical Officer) plans to sell 4K shares of NovaBridge Biosciences (at $2.79 each, total $10K) Filed: Mar 18, 2026 | ID: 000121